+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Biotechnology Market Size, Share & Trends Analysis Report by Technology (DNA Sequencing, Nanobiotechnology), by Application (Health, Bioinformatics), by Region, and Segment Forecasts, 2021-2028

  • ID: 4396357
  • Report
  • March 2021
  • Region: Global
  • 150 Pages
  • Grand View Research

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • CELGENE CORPORATION
  • Gilead
  • Lonza
  • Novartis AG
The global biotechnology market size is expected to reach USD 2.44 trillion by 2028. It is expected to expand at a CAGR of 15.83% from 2021 to 2028. The factors driving the market include favorable government policies, the launch of new and advanced products, robust investment in the biotechnology sector, and rising demand for synthetic biology.



Robust funding through alliance investment in start-up biotechnology companies for adopting new and advanced products is contributing to market growth. For instance, in February 2021, Illumina, Inc. invested in nine new genomics companies through Illumina Accelerator in 4 start-ups in the U.K. and 5 start-ups in the U.S. The companies include MultiplAI Health LTD.; BiotaX Labs LTD.; Mitra Bio Limited; Broken String Biosciences Limited; Flightpath Biosciences, Inc.; Doloromics Inc.; Oshun Medical Inc.; Parallel Health Inc.; and Rubik Therapeutics, Inc. Illumina Accelerator is an initiative through which selected startups can access to seed investment, genomics expertise, and Illumina sequencing systems and reagents and seek business guidance.

The bioinformatics application segment is expected to expand at the fastest CAGR from 2021 to 2028 owing to the increasing adoption of these tools for analyzing complex sequencing data. By technology, nanobiotechnology is expected to expand at a lucrative growth rate of 16.8% over the forecast period owing to the growing focus on nanotechnologies for efficient drug delivery and increasing research using this technology.

Supportive government initiatives are significantly contributing to market growth. For instance, in September 2020, the Government of India supported research institutes in agriculture biotechnology, including organic farming. Since the last 3 years, around USD 42.67 million had been invested to support this endeavor.

Moreover, the emergence of the SARS-COV-2 infection is driving the market. Companies are developing new solutions for combating the pandemic situation. For instance, in December 2020, Thermo Fisher Scientific Inc. announced CE-marking for TaqPath COVID-19 that can be used to perform in-vitro diagnosis of SARS-CoV-2, respiratory syncytial virus (RSV) A/B, and influenza A/B infections. The new kit will help in the detection and differentiation between diseases that have similar clinical symptoms.

Biotechnology Market Report Highlights

  • The health application segment accounted for the largest share of 48.64% in 2020 owing to the COVID-19 impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure
  • The DNA sequencing technology segment held the second-largest share in 2020 owing to its growing penetration in the development of precision medicines
  • North America held the largest share of 44.19% in 2020. Companies operating in the region are launching advanced solutions to cater to the needs of the biotechnology industry
  • For instance, in February 2021, Waters Corporation launched Waters ACQUITY PREMIER Solution. It is a next-generation liquid chromatography solution for improving analytical data quality
  • Asia Pacific is expected to expand at the fastest CAGR of 16.8% from 2021 to 2028 owing to favorable government initiatives and changes in drug approval regulations in India and China


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Biotechnology Market

What is the estimated value of the Biotechnology Market?

The Biotechnology Market was estimated to be valued at $1006.7 Billion in 2021.

What is the growth rate of the Biotechnology Market?

The growth rate of the Biotechnology Market is 13.5%, with an estimated value of $2440.0 Billion by 2028.

What is the forecasted size of the Biotechnology Market?

The Biotechnology Market is estimated to be worth $2440.0 Billion by 2028.

Who are the key companies in the Biotechnology Market?

Key companies in the Biotechnology Market include Gilead, AstraZeneca, CELGENE CORPORATION, Biogen, Abbott Laboratories, Amgen, Inc., Novo Nordisk A/S, Merck & Co. and Novartis AG.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • CELGENE CORPORATION
  • Gilead
  • Lonza
  • Novartis AG

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Industry Outlook, Trends & Scope
3.1 Market Trends & Outlook
3.2 Market Segmentation & Scope
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Declining prices of DNA sequencing
3.3.1.2 Presence of favorable government initiatives
3.3.1.3 Rising demand for agro-based products
3.3.1.4 Growing demand for synthetic biology
3.3.1.5 Robust penetration of biotechnology products & techniques in the management of COVID-19
3.3.1.6 Growing healthcare expenditure triggering the development of effective PM diagnostic & therapeutic procedure for cancer
3.4.2 Market restraint analysis
3.4.2.1 Ethical issues related to clinical trials
3.4.2.2 Risks associated with GM organisms and crops
3.4.2.3 Challenges associated with NGS implementation
3.4 Penetration & Growth Prospect Mapping for Technology, 2020
3.5 Company Market Share Analysis
3.6 Biotechnology -SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.7 Industry Analysis - Porter’s
3.8 COVID-19 Impact Analysis
3.8.1 Challenge Analysis
3.8.2 Opportunities Analysis
3.8.3 Key Development & Market Initiatives
Chapter 4 Market Categorization: Technology Estimates & Trend Analysis
4.1 Biotechnology Market: Technology Movement Analysis
4.2 Nanobiotechnology
4.2.1 Global Nanobiotechnology Market, 2017 - 2028 (USD Billion)
4.3 Tissue Engineering and Regeneration
4.3.1 Global Tissue Engineering and Regeneration Market, 2017 - 2028 (USD Billion)
4.4 DNA Sequencing
4.4.1 Global DNA Sequencing Market, 2017 - 2028 (USD Billion)
4.5 Cell-based Assays
4.5.1 Global Cell-based Assays Market, 2017 - 2028 (USD Billion)
4.6 Fermentation
4.6.1 Global Fermentation Market, 2017 - 2028 (USD Billion)
4.7 PCR Technology
4.7.1 Global PCR Technology Market, 2017 - 2028 (USD Billion)
4.8 Chromatography
4.8.1 Global Chromatography Instruments Market, 2017 - 2028 (USD Billion)
4.9 Others
4.9.1 Global Other Technologies Market, 2017 - 2028 (USD Billion)
Chapter 5 Market Categorization: Application Estimates & Trend Analysis
5.1 Biotechnology Market: Application Movement Analysis
5.2 Health
5.2.1 Global Health Biotechnology Market, 2017 - 2028 (USD Billion)
5.3 Food & Agriculture
5.3.1 Global Agriculture Biotechnology Market, 2017 - 2028 (USD Billion)
5.4 Natural Resources & Environment
5.4.1 Global Natural Resources & Environment Market, 2017 - 2028 (USD Billion)
5.5 Industrial Processing
5.5.1 Global Industrial Processing Market, 2017 - 2028 (USD Billion)
5.6 Bioinformatics
5.6.1 Global Bioinformatics Market, 2017 - 2028 (USD Billion)
5.7 Others
5.7.1 Global Other Applications Market, 2017 - 2028 (USD Billion)
Chapter 6 Market Categorization: Regional Estimates & Trend Analysis, by Application & Technology
6.1 Biotechnology Market Share by Region, 2020 & 2028
6.2 North America
6.2.1 North America Biotechnology Market, 2017 - 2028 (USD Billion)
6.2.2 U.S.
6.2.2.1 U.S. biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.2.2.2 U.S. biotechnology market, by application, 2017 - 2028 (USD Billion)
6.2.3 Canada
6.2.3.1 Canada biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.2.3.2 Canada biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3 Europe
6.3.1 Europe Biotechnology Market, 2017 - 2028 (USD Billion)
6.3.2 Germany
6.3.2.1 Germany biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.2.2 Germany biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3.3 U.K.
6.3.3.1 U.K. biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.3.2 U.K. biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3.4 France
6.3.4.1 France biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.4.2 France biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3.5 Spain
6.3.5.1 Spain biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.5.2 Spain biotechnology market, by application, 2017 - 2028 (USD Billion)
6.3.6 Italy
6.3.6.1 Italy biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.3.6.2 Italy biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Biotechnology Market, 2017 - 2028 (USD Billion)
6.4.2 China
6.4.2.1 China biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.2.2 China biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4.3 Japan
6.4.3.1 Japan biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.3.2 Japan biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4.4 India
6.4.4.1 India biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.4.2 India biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4.5 South Korea
6.4.5.1 South Korea biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.5.2 South Korea biotechnology market, by application, 2017 - 2028 (USD Billion)
6.4.6 Australia
6.4.6.1 Australia biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.4.6.2 Australia biotechnology market, by application, 2017 - 2028 (USD Billion)
6.5 Latin America
6.5.1 Latin America Biotechnology Market, 2017 - 2028 (USD Billion)
6.5.2 Brazil
6.5.2.1 Brazil biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.5.2.2 Brazil biotechnology market, by application, 2017 - 2028 (USD Billion)
6.5.3 Mexico
6.5.3.1 Mexico biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.5.3.2 Mexico biotechnology market, by application, 2017 - 2028 (USD Billion)
6.6 Middle East & Africa
6.6.1 Middle East & Africa Biotechnology Market, 2017 - 2028 (USD Billion)
6.6.2 South Africa
6.6.2.1 South Africa biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.6.2.2 South Africa biotechnology market, by application, 2017 - 2028 (USD Billion)
6.6.3 Saudi Arabia
6.6.2.1 Saudi Arabia biotechnology market, by technology, 2017 - 2028 (USD Billion)
6.6.2.2 Saudi Arabia biotechnology market, by application, 2017 - 2028 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Gilead
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 AstraZeneca
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 CELGENE CORPORATION
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Biogen
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Abbott Laboratories
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Amgen, Inc.
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Novo Nordisk A/S
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Merck & Co.
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Johnson & Johnson
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Novartis AG
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product Benchmarking
7.3.10.4 Strategic Initiatives
7.3.11 Sanofi Aventis
7.3.11.1 Company Overview
7.3.11.2 Financial Performance
7.3.11.3 Product Benchmarking
7.3.11.4 Strategic Initiatives
7.3.12 F. Hoffmann-La Roche Ltd.
7.3.12.1 Company Overview
7.3.12.2 Financial Performance
7.3.12.3 Product Benchmarking
7.3.12.4 Strategic Initiatives
7.3.13 Pfizer, Inc.
7.3.13.1 Company Overview
7.3.13.2 Financial Performance
7.3.13.3 Product Benchmarking
7.3.14.4 Strategic Initiatives
7.3.14 Lonza
7.3.14.1 Company Overview
7.3.14.2 Financial Performance
7.3.14.3 Product Benchmarking
7.3.14.4 Strategic Initiatives
List of Tables
Table 1 Healthcare expenditure levels, 2019
Table 2 Various approaches in regenerative medicine for dermatological use
Table 3 North America: Clinical studies using HCT for hematopoietic and non-hematopoietic conditions (2016)
Table 4 North America biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 5 North America biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 6 U.S. biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 7 U.S. biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 8 Canada biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 9 Canada biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 10 Europe biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 11 Europe biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 12 Germany biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 13 Germany biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 14 U.K. biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 15 U.K. biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 16 France biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 17 France biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 18 Italy biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 19 Italy biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 20 Spain biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 21 Spain biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 22 Asia Pacific biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 23 Asia Pacific biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 24 Japan biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 25 Japan biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 26 Main monographs published in china
Table 27 China biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 28 China biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 29 India biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 30 India biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 31 South Korea biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 32 South Korea biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 33 Australia biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 34 Australia biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 35 Latin America: Current initiatives and opportunities
Table 36 Latin America biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 37 Latin America biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 38 Brazil biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 39 Brazil biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 40 Mexico biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 41 Mexico biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 42 MEA biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 43 MEA biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 44 South Africa biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 45 South Africa biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
Table 46 Saudi Arabia biotechnology market estimates & forecasts, by application, 2017 - 2028 (USD Billion)
Table 47 Saudi Arabia biotechnology market estimates & forecasts, by technology, 2017 - 2028 (USD Billion)
List of Figures
Fig. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for technology, 2020
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Global Biotechnology market: Technology outlook key takeaways
FIG. 16 Global Biotechnology market: Technology movement analysis
FIG. 17 Global DNA sequencing market, 2017 - 2028 (USD Billion)
FIG. 18 Global nanobiotechnology market, 2017 - 2028 (USD Billion)
FIG. 19 Global tissue engineering and regeneration market, 2017 - 2028 (USD Billion)
FIG. 20 Global fermentation market, 2017 - 2028 (USD Billion)
FIG. 21 Global cell-based assays market, 2017 - 2028 (USD Billion)
FIG. 22 Global PCR technology market, 2017 - 2028 (USD Billion)
FIG. 23 Global chromatography market, 2017 - 2028 (USD Billion)
FIG. 24 Global others market, 2017 - 2028 (USD Billion)
FIG. 25 Global biotechnology market: Application outlook key takeaways
FIG. 26 Global biotechnology market: Application movement analysis
FIG. 27 Global health market, 2017 - 2028 (USD Billion)
FIG. 28 Global food & agriculture market, 2017 - 2028 (USD Billion)
FIG. 29 Global natural resources & environment market, 2017 - 2028 (USD Billion)
FIG. 30 Global industrial processing market, 2017 - 2028 (USD Billion)
FIG. 31 Global bioinformatics market, 2017 - 2028 (USD Billion)
FIG. 32 Global others market, 2017 - 2028 (USD Billion)
FIG. 33 Regional market place: Key takeaway
FIG. 34 Biotechnology regional outlook, 2020 & 2028
FIG. 35 North America biotechnology market, 2017 - 2028 (USD Billion)
FIG. 36 U.S biotechnology market, 2017 - 2028 (USD Billion)
FIG. 37 Canada biotechnology market, 2017 - 2028 (USD Billion)
FIG. 38 Europe biotechnology market, 2017 - 2028 (USD Billion)
FIG. 39 Germany biotechnology market, 2017 - 2028 (USD Billion)
FIG. 40 U.K. biotechnology market, 2017 - 2028 (USD Billion)
FIG. 41 France biotechnology market, 2017 - 2028 (USD Billion)
FIG. 42 Spain biotechnology market, 2017 - 2028 (USD Billion)
FIG. 43 Italy biotechnology market, 2017 - 2028 (USD Billion)
FIG. 44 Asia Pacific biotechnology market, 2017 - 2028 (USD Billion)
FIG. 45 Japan biotechnology market, 2017 - 2028 (USD Billion)
FIG. 46 China biotechnology market, 2017 - 2028 (USD Billion)
FIG. 47 India biotechnology market, 2017 - 2028 (USD Billion)
FIG. 48 Australia biotechnology market, 2017 - 2028 (USD Billion)
FIG. 49 South Korea biotechnology market, 2017 - 2028 (USD Billion)
FIG. 50 Latin America biotechnology market, 2017 - 2028 (USD Billion)
FIG. 51 Brazil biotechnology market, 2017 - 2028 (USD Billion)
FIG. 52 Mexico biotechnology market, 2017 - 2028 (USD Billion)
FIG. 53 Middle East & Africa biotechnology market, 2017 - 2028 (USD Billion)
FIG. 54 South Africa biotechnology market, 2017 - 2028 (USD Billion)
FIG. 55 Saudi Arabia biotechnology market, 2017 - 2028 (USD Billion)
FIG. 55 Strategy framework
FIG. 56 Participant categorization
Note: Product cover images may vary from those shown
  • Gilead
  • AstraZeneca
  • CELGENE CORPORATION
  • Biogen
  • Abbott Laboratories
  • Amgen, Inc.
  • Novo Nordisk A/S
  • Merck & Co.
  • Johnson & Johnson
  • Novartis AG
  • Sanofi Aventis
  • F. Hoffmann-La Roche Ltd.
  • Pfizer, Inc.
  • Lonza
Note: Product cover images may vary from those shown

Loading
LOADING...